Literature DB >> 32553286

Vascularity of meningiomas.

Shaheryar F Ansari1, Kushal J Shah2, Wael Hassaneen3, Aaron A Cohen-Gadol4.   

Abstract

Information on the vascular supply to meningiomas is critical to the neurosurgeon. Most meningiomas are supplied by the external carotid artery, though many get pial contribution as well. Angiogenesis is critical for these neoplasms to grow. Vascular endothelial growth factor (VEGF) has been a popular target of research to decrease angiogenesis. Peritumoral brain edema (PTBE) is occasionally seen in meningiomas, which makes surgical resection more challenging. The exact cause of PTBE remains unclear, but a number of factors have been postulated to contribute. Assessment of the vascularity of meningiomas is best carried out with angiography, but noninvasive techniques are improving, diminishing the need for more invasive imaging. Embolization of tumors can be performed to minimize perioperative blood loss and potentially lower surgical morbidity. However, it has not been shown to improve outcomes, and procedural risks exist. Higher grade tumors commonly have higher vascularity. Higher vascular meningiomas are more likely to recur and have higher levels of VEGF. The vascularity of meningiomas remains a topic of interest and is the focus of many research projects.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Embolization; Noninvasive vascular imaging; Peritumoral brain edema; Vascular endothelial growth factor; Vascular supply

Mesh:

Substances:

Year:  2020        PMID: 32553286     DOI: 10.1016/B978-0-12-804280-9.00010-X

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  1 in total

1.  PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: Implications for Pathophysiology and Tumor Outcomes.

Authors:  Michelle Roytman; Sean Kim; Shannon Glynn; Charlene Thomas; Eaton Lin; Whitney Feltus; Rajiv S Magge; Benjamin Liechty; Theodore H Schwartz; Rohan Ramakrishna; Nicolas A Karakatsanis; Susan C Pannullo; Joseph R Osborne; Jonathan P S Knisely; Jana Ivanidze
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.